Dynamic Metabolic Zonation of the Hepatic Glucose Metabolism Is Accomplished by Sinusoidal Plasma Gradients of Nutrients and Hormones by Berndt, Nikolaus & Holzhütter, Hermann-Georg
ORIGINAL RESEARCH
published: 12 December 2018
doi: 10.3389/fphys.2018.01786
















This article was submitted to
Gastrointestinal Sciences,
a section of the journal
Frontiers in Physiology
Received: 16 August 2018
Accepted: 28 November 2018
Published: 12 December 2018
Citation:
Berndt N and Holzhütter H-G (2018)
Dynamic Metabolic Zonation of the
Hepatic Glucose Metabolism Is
Accomplished by Sinusoidal Plasma
Gradients of Nutrients and Hormones.
Front. Physiol. 9:1786.
doi: 10.3389/fphys.2018.01786
Dynamic Metabolic Zonation of the
Hepatic Glucose Metabolism Is
Accomplished by Sinusoidal Plasma
Gradients of Nutrients and Hormones
Nikolaus Berndt 1,2 and Hermann-Georg Holzhütter 1*
1Computational Biochemistry Group, Institute of Biochemistry, Charite—University Medicine Berlin, Berlin, Germany,
2 Institute for Computational and Imaging Science in Cardiovascular Medicine, Charite—University Medicine Berlin, Berlin,
Germany
Being the central metabolic organ of vertebrates, the liver possesses the largest repertoire
of metabolic enzymes among all tissues and organs. Almost all metabolic pathways are
resident in the parenchymal cell, hepatocyte, but the pathway capacitiesmay largely differ
depending on the localization of hepatocytes within the liver acinus-a phenomenon that is
commonly referred to as metabolic zonation. Metabolic zonation is rather dynamic since
gene expression patterns of metabolic enzymes may change in response to nutrition,
drugs, hormones and pathological states of the liver (e.g., fibrosis and inflammation).
This fact has to be ultimately taken into account in mathematical models aiming at
the prediction of metabolic liver functions in different physiological and pathological
settings. Here we present a spatially resolved kinetic tissue model of hepatic glucose
metabolism which includes zone-specific temporal changes of enzyme abundances
which are driven by concentration gradients of nutrients, hormones and oxygen along
the hepatic sinusoids. As key modulators of enzyme expression we included oxygen,
glucose and the hormones insulin and glucagon which also control enzyme activities
by cAMP-dependent reversible phosphorylation. Starting with an initially non-zonated
model using plasma profiles under fed, fasted and diabetic conditions, zonal patterns of
glycolytic and gluconeogenetic enzymes as well as glucose uptake and release rates are
created as an emergent property. We show that mechanisms controlling the adaptation
of enzyme abundances to varying external conditions necessarily lead to the zonation of
hepatic carbohydrate metabolism. To the best of our knowledge, this is the first kinetic
tissue model which takes into account in a semi-mechanistic way all relevant levels of
enzyme regulation.
Keywords: metabolism, metabolic zonation, kinetic model, multiscale model, gene expression
INTRODUCTION
The tightly controlled switch between hepatic uptake and release of glucose keeps the plasma
glucose concentrations within a range between 4 and 10mM despite largely varying carbohydrate
intake and utilization. This homeostatic function of the liver with respect to plasma glucose
is achieved by several enzyme-regulatory mechanisms acting on different time scales. On the
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short term, hormone-dependent reversible enzyme
phosphorylation and changes of reaction rates elicited by
concentration changes of reaction substrates/products and
allosteric modulators enable a metabolic response within seconds
or minutes. Recurrent activation of these fast regulatory modes
is typically accompanied by slow changes in the abundance of
metabolic enzymes on a time scale of hours to days (Hopgood
et al., 1973; Weinberg and Utter, 1980). Both the fast and slow
mode of enzyme regulation are important for the regulation of
the glucose exchange flux between hepatocytes and blood plasma
(Bulik et al., 2016), Owing to concentration gradients of oxygen,
metabolites, hormones, and morphogens along the hepatic
capillaries (sinusoids) the expression of metabolic enzymes may
differ in various zones of the liver acinus. For example, the
oxygen pressure decreases by 50% along the porto-central axis
of the acinus (Jungermann and Kietzmann, 2000). This goes in
line with the number and structure of mitochondria (Schmucker
et al., 1978) and glycolytic capacities in the periportal and
pericentral zone (Braeuning et al., 2006). Hepatocytes close to
the portal pole (zone 1) experiencing the highest concentration
of oxygen pressure are predestined for strong ATP-demanding
anabolic pathways like gluconeogenesis and urea synthesis.
Contrary, hepatocytes close to the venous pole of the acinus
(zone 3) experience the lowest oxygen concentrations and
thus possess a high glycolytic capacity, a typical feature of cells
working under conditions of permanent oxygen deprivation.
The heterogeneous allocation of gluconeogenetic and glycolytic
capacities to different hepatocytes along the porto-central axis
may even result in a situation where a certain fraction of glucose
produced by periportal cells is used to fuel the glycolysis of
pericentral cells (Berndt et al., 2018).
Several blood-born factors have been identified as regulators
of zone-dependent gene expression of metabolic enzymes.
Oxygen, glucose, the hormones glucagon and insulin, the
morphogens Wnt and hedgehog and the growth factor HGF
belong to the best studied factors. The various factors appear
to act in a hierarchical fashion whereby the gradients of
morphogens and growth factors create a basic expression pattern
that is further modulated by nutrition-related factors such as
oxygen, glucose, fatty acids and the hormones insulin and
glucagon. In this work, we will focus on the latter group of
modifiers, i.e., we restrict our model to the metabolic response
of the liver to nutritional challenges and oxygen availability.
Metabolic adaptation of hepatocytes to varying oxygen
pressures is mainly controlled by hypoxia-inducible transcription
factors (HIFs), heterodimeric complexes consisting of a
constitutively expressed β-subunit and an oxygen-sensitive α-
subunit. In the liver, HIF-1α regulates primarily glycolytic genes
whereas HIF-2α is known to primarily regulate genes involved
in cell proliferation and iron metabolism (Ramakrishnan and
Shah, 2017). In line with the falling oxygen pressure along the
porto-central axis, HIFαs were found with higher levels in the
less aerobic pericentral zone (Kietzmann et al., 2001). Besides
oxygen, the pancreatic hormones insulin and glucagon are
important drivers of zone-dependent differences in enzyme
activities. The regulatory role of these hormones is 2-fold. They
control the cellular cAMP level in an antagonistic manner and
thus exert opposite effects on the reversible phosphorylation
of key regulatory enzymes of glycolysis and gluconeogenesis
as PFK2, PK, and PEPCK. The hepatic clearance of the two
hormones by endocytic uptake into hepatocytes creates a
concentration gradient along the porto-central axis which
entails zone-dependent differences in the phosphorylation level
of interconvertible enzymes. With respect to gene expression
of metabolic enzymes, insulin and glucagon also control the
efficiency of several transcription factors as ChREBP, SREBP-1c,
CREB, and Foxo (Han et al., 2016). Both actions of glucagon
and insulin are tightly interrelated and function in part through
the same mechanisms. For example, the cAMP-activated
protein kinase A (PKA) is responsible for phosphorylation of
interconvertible enzymes such as FBPFK2 and PK, as well as for
the phosphorylation of the transcription factors ChREBP and
CREP (Uyeda and Repa, 2006). cAMP is produced by glucagon-
induced activation of the adenylate cyclase and degraded by
insulin-stimulated cAMP phosphodiesterase. Consequently,
the protein level of key regulatory enzymes reflects the integral
hormone levels over longer time periods.
In this work we included dynamic changes in the abundance
of metabolic enzymes into our previously developed multi-scale
tissue model of hepatic glucose metabolism (Berndt et al., 2018).
The rates of protein synthesis and degradation were modeled
by phenomenological rate equations which were parameterized
by using experimentally determined protein levels at varying
concentrations of oxygen, glucose, insulin, and glucagon. The
central aims of our work were (i) to provide a proof of principle
for integrating in a self-consistent manner the temporal gene
expression of enzymes into kineticmodels of cellular metabolism,
(ii) to lend further support to the concept of post-differentiation
patterning according to which metabolic zonation is driven by
gradients of oxygen, nutrients and hormones in the capillary
blood and (iii) to present a modeling approach that obviates
the requirement to measure the cellular abundance of metabolic
enzymes (e.g., by quantitative proteomics) in different physical
states of the liver, a procedure burdened with many problems as,
for example, invasive tissue sampling and protein quantification
in cells separated from different zones.
MODEL DESCRIPTION
The model combines a mathematical model of the sinusoidal
tissue unit (STU) (Berndt et al., 2018) with a kinetic model of
the protein turnover of key regulatory enzymes.
Compartment Model of Metabolite and
Hormone Transport in the Sinusoidal
Tissue Unit (STU)
Structurally, the STU is defined by a single sinusoid, the adjacent
space of Disse and a monolayer of hepatocytes flanking the
space of Disse (see Figure 1A). Functionally, the model describes
the exchange of oxygen, metabolites and hormones between the
sinusoidal blood, the space of Disse and the hepatocytes and
the glucose metabolism within hepatocytes. The transport of
metabolite and hormones within the STU is driven by diffusion
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FIGURE 1 | Schematic model representation (A) sinusoidal blood flow model describing blood flow, nutrient and hormone distribution within the sinusoids. The model
encompasses a single sinusoid, the adjacent space of Disse and the surrounding layer of hepatocytes. It is described by morphological parameters (blood vessel
radius, thickness of the space of Disse, hepatocyte thickness, hepatocyte number, sinusoid length, degree of fenestration), and systemic parameters (central and
portal vein hydrostatic pressure, plasma and lymph oncotic pressure, diffusion coefficients); (B) model of carbohydrate metabolism encompassing glycolysis,
glyconeogenesis and glycogen synthesis and utilization. These pathways comprise the enzymes Glucokinase (GK), Glucose-6-phosphate isomerase (GPI),
Phosphofructokinase 1 (PFK1), Aldolase (ALD), Triosephosphate isomerase (TPI), Glyceraldehydephosphate dehydrogenase (GAPDH), Phosphoglycerate kinase
(PGK), Phosphoglycerate mutase (PGM), Enolase (EN), Pyruvate kinase (PK) Lactate dehydrogenase (LDH), Glucose-6-phosphate phosphatase (G6P),
Phosphofructokinase 2 (PFK2), Fructose-2,6-bisphosphatase (FBP2), Fructose-1,6-bisphosphatase (FBP1), Phosphoenolpyruvate carboxykinase (PEPCK), Pyruvate
carboxylase (PC), Nucleoside-diphosphate kinase (NDK), Malate dehydrogenase (MDH), Pyrophosphatase (PPASE), Glucose-1-phosphate isomerase (P1PI),
Glycuronosyltransferase (UGT), Glycogen phosphorylase (GP), Glycogen synthase (GS) and transporters (ER <-> cytosol: Glucose-6-phosphate transporter (Glc6PT),
Glucose transporter (GlcT); mitochondrion <-> cytosol: Pyruvate transporter (PYRT), Phosphoenolpyruvate transporter (PEPT), Malate transporter (MALT); extern
<-> cytosol: Glucose transporter 2 (GLUT2), Lactate transporter (LACT). Enzymes that are phosphorylated or dephosphorylated in response to insulin (Ins) and
glucagon (Glu) stimulus are marked by a yellow P, allosteric modification of enzymes is marked by a red A. The model contains the metabolites: glucose (Glc),
glucose-6-phosphate (Glc6P), fructose-6-phosphate (Fru6P), fructose-1,6-bisphosphate (Fru16P2), glyceraldehydephosphate (GraP), dihydroxyacetonephosphate
(DHAP), 1,3-bisphosphoglycerate (13P2G), 3-phosphoglycerate (3PG), 2-phosphoglycerate (2PG), phosphoenolpyruvate (PEP), pyruvate (Pyr), lactate (Lac), malate
(Mal), oxaloacetate (OA), glucose-1-phosphate (Glc1P), UDP-glucose (UDP-glc), glycogen, fructose-2,6-bisphosphate (Fru26P2). The cofactors NADH, NAD, ATP,
ADP, UTP and UDP are not treated as dynamic variables. All physiological metabolites produced or consumed in the hepatocyte during glycolysis and
gluconeogenesis are comprised into lactate. Figures adapted from Berndt et al. (2018).
and directional transport along the flow of water and blood.
Lateral blood flow in the vessel is described by Hagen-Poiseuille
law for fluid flow through a cylinder, water flow in the space
of Disse is described by Hagen-Poiseuille law for fluid flow in
a hollow cylinder. Exchange of water between the vessel and
the space of Disse is driven by hydrostatic and oncotic pressure
difference between the blood vessel and the space of Disse.
Conceptually, the STU was divided into NH zones, where NH
is the number of hepatocytes along the porto-central axis. Each
zone is made up of the sinusoid volume, the space of Disse and
the hepatocyte (Figure 1A). Within one zone, the concentration
of metabolites and hormones is given by a single value. The
mathematical description of the STU model and a complete list
of parameters used can be found in Berndt et al. (2018).
Kinetic Model of Hepatocyte Glucose
Metabolism
The reaction scheme for the glucose metabolism of a single
hepatocyte is depicted in Figure 1B. It consists of the
pathways for glycolysis, glyconeogenesis, glycogen synthesis
and degradation. The time-dependent variation of metabolite
concentrations is given by first-order differential equations. The
liver specific enzymatic rate laws take into account substrate
regulation, allosteric regulation and hormonal regulation by
hormone-dependent reversible phosphorylation (Bulik et al.,
2016).
Kinetic Model of Hormonal Signaling
The pancreatic hormones glucagon and insulin are released into
the portal vein in response to the plasma glucose concentration
and are partially cleared during their passage through the liver.
Hence, there is a difference between their plasma concentrations
determined in peripheral blood samples and effective intra-
hepatic concentrations. This difference was taken into account
by setting the concentration values of insulin and glucagon in
the periportal blood to the 2-fold of their plasma values (Balks
and Jungermann, 1984). The rate of intra-hepatic hormone
clearance via receptor binding and subsequent endocytosis was
put proportional to the binding and signaling strength of the
hormone. We used empirical transfer functions to describe the
relationship between glucose and hormone concentrations in the
plasma and the relationship between and the phosphorylation
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state of interconvertible enzymes as described in Bulik et al.
(2016). A detailed description of the functions and their
construction can be found in Berndt et al. (2018).
Kinetic Model of Protein Turnover
The temporal change of the protein level PENZ of a metabolic
enzyme (ENZ) is given by the difference between the rates of






PENZ = vENZ(E) = vENZsyn (E)− v
ENZ
deg (E) (1)
The right-hand side of equation (1), vENZ(E), represents the
turnover rate of the enzyme protein. It is controlled by
modulators affecting either the synthesis or the degradation
or both. Note that the enzyme level PENZ scales linearly with
the maximal rate of the enzyme. The rate equations of protein
synthesis and degradation both depend on the momentary
concentration of at least one of the four modulators Ei, i =
1 (insulin), i = 2 (glucagon), i = 3 (glucose), i = 4 (oxygen)
considered in the model. The general structure of the rate









where kENZi is a constant determining the basal synthesis rate
and fi is a nonlinear function of the i-th modulator. The “+”
sign holds if Ei is an activator (inductor) of protein synthesis,
the (–) sign holds If Ei is an inhibitor (repressor) . If Ei has
not been reported so far to exert an effect on the protein
synthesis of enzyme ENZ it holds kENZi = 1 and f
ENZ
i = 0




in such a manner that for a normal 24 h plasma profile (see
below) the zone- and time averaged protein levels coincided
with the stationary protein levels as reported in Bulik et al.
(2016). Numerical values of all other kinetic parameters were
obtained by adjusting the rate equations to experimentally
determined protein levels at varying concentrations of the four
possible modulators (see Supplement 1). Table 1 depicts the rate
equations for the synthesis and degradation of those enzymes
of hepatic glucose metabolism possessing in the model timely
variable protein levels.
In order to quantify the sensitivity of the turnover rate vENZ(E)
of a protein against small changes of an modulator E, we used the








Figure 2 depicts the sensitivity coefficients for the turnover
rates of the nine enzyme proteins with variable expression
level as function of the four modulators oxygen (I), glucagon
(II), insulin (III) and glucose (IV). Except for the sensitivities
of the PEPCK and G6PP turnover with respect to glucagon
and glucose, respectively, the extremum of all other sensitivity
characteristics lies within the reported physiological range of
the related modulators (green-shaded areas in Figure 2). The
sensitivity of G6PP turnover with respect to glucose becomes
important in the diabetic case, where glucose levels can exceed
20mM (see below).
RESULTS
Dynamic Metabolic Zonation in a Well-Fed
State of the Rat
First, we used the model to simulate the temporal variation of
enzyme abundances, metabolite concentrations and fluxes within
the various zones along the porto-central axis of the STU. The
simulation was initiated with identical abundance of enzymes
along the sinusoid which we set to the stationary mean protein
abundance used in Bulik et al. (2016). We used as model input
the diurnal glucose profile reported for the healthy normal liver
of a fed rat (La Fleur et al., 1999) and carried out the numerical
integration of the model over several 24 h cycles until there was
no change in the 24 h enzyme and metabolite profiles.
Even with identical enzyme abundances across all hepatocytes,
there occurs a progressive decline of hormone plasma levels from
the portal to the central pole due to the ongoing hormone uptake
by hepatocytes in each zone. Moreover, oxygen uptake in one
zone diminishes the available oxygen pressure seen by the cells
in the adjacent zone toward the pericentral pole. As oxygen is
not part of the model, we assumed a linear decrease in oxygen
partial pressure from 90 mmHG in the periportal zone to 35mm
HG in the pericentral zone (Jungermann and Kietzmann, 2000;
Allen et al., 2005). These initial gradients of hormones, glucose
and oxygen feed back to the level of metabolic enzymes so that
finally zone-dependent patterns of both enzyme abundances and
metabolic variables (see Figures 3, 4) are generated.
Figures 3A–C depicts the timely variation of glucose, insulin,
glucagon in various sinusoidal compartments. Intriguingly, the
highest glucose concentrations in the very portal zone (see
red curve in Figure 3A) are paralleled by the lowest glucose
concentrations in the very central zone (green curve). This
seemingly paradoxical situation is due to the fact that the high
level of insulin and low level of glucagon strongly increase the
glucose uptake capacity of hepatocytes such that the otherwise
strong zone-dependent differences in the glucose exchange flux
(see Figure 3E) almost disappear. The simulation also reveals
large zone-dependent differences in the cellular dynamics of
glycogen (Figure 3D). The variation of the glycogen content in
portal cells is much more pronounced than in central cells.
The time-dependent variation in the protein levels of key
glycolytic and gluconeogenetic enzymes in different zones are
depicted in Figure 4. The uniform overall shape of the curves
reflects essentially the daily variation of the plasma glucose
level. Generally, the daily fluctuations of enzyme levels around
their 24 h mean hardly exceed 10%. Thus, as long as the liver
is repeatedly confronted with the same 24 h plasma profile of
metabolites and hormones, timely variations of protein levels
should have only a marginal impact on the hepatic control of the
plasma glucose level.
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TABLE 1 | Synthesis and degradation rates of the regulatory enzymes of hepatic carbohydrate.
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In contrast to the modest time-dependent variations of
protein levels, the computed zone-dependent differences of
enzyme levels display a large scatter. The maximal differences
between the enzyme endowment of hepatocytes closest to
the portal and central pole lie between 0.1 [e.g., glucose
transporter (glcT) and phosphofructokinase 1 (pfk1)] and 4.5
[phosphoenolpyruvate kinase (pepck)]. For the validation of
these computational predictions, we calculated the 24 h-average
protein levels of the first (most portal) and last (most central)
hepatocyte and compared the ratio of the computed average
protein levels with experimental data (see first columns for each
enzyme in Figure 5). We further compared the ratio of 24 h- and
zone-averaged mean protein levels between a fed and fasted rat
and a diabetic and normal rat.
This analysis provided a good concordance between
theoretical and experimental results. The only exception
is the pyruvate carboxylase, a key regulatory enzyme of
gluconeogenesis, were portal to central gradients could not
be univocally explained by the reported oxygen dependency.
Oxygen dependency accounts only for about 35% percent of the
observed zonation (see Table 1 and Supplement 1).
Dynamic Metabolic Zonation of the Liver
During Adaptation to Fasting
Next, we studied how the zonation of metabolic enzymes is
affected if the liver has to cope with a fundamentally different
nutritional regime. To this end, we simulated the zone-dependent
dynamic changes of protein levels and metabolites during the
transition from a fed state of the rat to a fasting state. The
simulation started with the stable 24 h zonated enzyme profile
that is established if the liver experiences recurrently the same
plasma profile of a fed rat (see above). At time t = 24 h, the
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FIGURE 2 | Sensitivity coefficients of protein turnover rates defined in equation (3) as function of modulator concentrations.
I Sensitivity of protein turnover rates with respect to oxygen of (A) GK, (B) FBPFK2, (C) PK, (D) PEPCK
II Sensitivity of protein turnover rates with respect to (E) G6PP, (F) FBP1, (G) FBPFK2, (H) PK, (I) PC, (J) PEPCK
III Sensitivity of protein turnover rates with respect to (K) GK, (L) PFK1, (M) PK, (N) PEPCK
IV Sensitivity of protein turnover rates with respect to (O) GlcT, (P) G6PP
The green-shades areas indicate the reported physiological concentration range of the respective modulator.
FIGURE 3 | Diurnal variations in the plasma levels of glucose (A), insulin (B), glucagon (C), cellular glycogen (D) and the glucose exchange flux (E) in different zones
along the porto-central axis. The different curves refer to different spatial positions of hepatocytes, counted from periportal (red curve) to percentral (green curve). The
bold blue line refers to the means values of the shown variable. Note that the red curves (= most portal cell) for the hormones and glucose are identical with their
plasma profiles.
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FIGURE 4 | Diurnal variations in the relative abundance of glycolytic and gluconeogenetic enzymes within hepatocytes along the porto-central axis of a well-fed rat.
The curves illustrate the relative deviation of protein abundances from the overall spatial and 24h- mean (=24 h mean of the bold red curve). From the top to the
bottom, the different curves refer to the spatial position of the hepatocyte counted from periportal to percentral. The bold red line refers to the average protein
abundance across all cells. (A) GlcT, (B) G6PP, (C) GK, (D) PFK1, (E) FBPPFK1, (F) PFK2, (G) FBPPFK2, (H) PK, (I) PC, (J) PEPCK.
plasma profile of the fed rate was replaced by plasma profile of
a fasted rat (La Fleur et al., 1999). The latter was only available
for a time range of 24 h of fasting. After about 16 h of fasting,
stable values of plasma metabolites were reached. Therefore, we
used for time points t > 48 h (i.e., >24 h of fasting) for the model
input a plasma profile that was composed of 6 repetitions of the
last part (16–24 h) of the 24 h fasting plasma profile. As shown in
Figure 6, the fed-to-fasting transition evokes a significant rise in
the abundance of key gluconeogenetic enzymes (GlcT, FBP1, PC,
PEPCK) and drop in the abundance of key glycolytic enzymes
(GK, PFK1, PFK2, FBP2, PK) in all zones. For two enzymes, the
GlcT and the PEPCK, the zone-dependent protein differences
becomemore pronounced compared to the fed state. By contrast,
for the GK, FBP1, GSPP, and PK the zone-dependent protein
differences became smaller.
The computed changes of enzyme profiles toward a more
gluconeogenetic phenotype are accompanied by significant
alterations of the intra-sinusoidal glucose gradient and the zone-
dependent differences in the glucose exchange rate (Figure 7).
Compared with the fed state, the porto-venous glucose difference
becomes much larger in the fasted state (Figure 7A). The same
holds for the glucose exchange rate (Figure 7D).
In agreement with experimental data (Babcock and Cardell,
1974), the glycogen stores are almost depleted after about 1 day
of fasting when the levels of insulin and glucagon have adopted
a new stable temporal profile. Notably, also for the fasted state,
the computed average protein abundance ratios are in good
agreement with experimental data which further substantiates
the reliability of the model (see Figure 5).
Figure 8 illustrates the importance of dynamic zonation for
the adaptation of the porto-venous glucose difference (AVGD)
to a specific nutritional regime. Regulation of interconvertible
enzymes by hormone-dependent phosphorylation alone, i.e., at
fixed protein levels of the fed state (blue line), would result in an
AVGD of about 3.5mM for the typical range of portal glucose
concentrations in the fasted state (red shaded area). Dynamic
adaption of protein levels enlarges the AVGD to about 7mM (red
line) thus rendering the liver to a strong glucose producer in the
fasted state.
Dynamic Metabolic Zonation of the Liver in
Diabetes Type II (“Diabetic Liver”)
Late diabetes type 2 is characterized by long persistence of high
postprandial plasma glucose levels, reduced insulin levels (hypo-
insulinemia) and elevated glucagon levels (hyper-glucagonemia).
It is mainly the shift in the insulin/glucagon ratio that renders
the liver to a glucose producer which on top of the insulin-
resistant muscle and adipose tissue contributes to high plasma
glucose levels. We tested whether our model can also correctly
describe this metabolic abnormality and the observed changes of
protein abundances in different zones. To this end, we used the
glucose-hormone transfer function constructed for the diabetic
case (see Bulik et al., 2016) to calculate the phosphorylation
state of interconvertible enzymes and confronted the model over
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FIGURE 5 | Ratio of enzyme levels in hepatocytes. Red circles indicate the computed ratio of protein levels. Green circles and gray bars indicate the mean value and
the range of variability of various experimentally determined ratios. First columns (pc): Portal-to-central ratios (= 24h-averaged protein levels between hepatocyte #1
and hepatocyte # 25) for the well-fed state of the rat. Experimental data were taken from (Sharma et al., 1964; Katz et al., 1977a,b; Trus et al., 1980; Jungermann and
Katz, 1982, 1989; Probst et al., 1982; Teutsch and Lowry, 1982; Miethke et al., 1985; Quistorff, 1985; Wölfle and Jungermann, 1985; Morselt et al., 1987; Chen and
Katz, 1988; Wals et al., 1988; Evans et al., 1989; Frederiks et al., 1991; Jones and Titheradge, 1996; Minchenko et al., 2003). Second columns (ff): Fed-to-fasted
ratios of 24h- and zone-averaged mean enzyme levels. Experimental data taken from (Dipietro and Weinhouse, 1960; Wimhurst and Manchester, 1970b; Ballard and
Hopgood, 1973; Bock et al., 1973; Zalitis and Pitot, 1979; Cladaras and Cottam, 1980; Neely et al., 1981; Bahnak and Gold, 1982; Van Schaftingen and Hers, 1983;
Donofrio et al., 1984; Colosia et al., 1988; Crepin et al., 1988; Thorens et al., 1990; Giffin et al., 1993; Gannon and Nuttall, 1997). Third columns (nd):
Normal-to-diabetic ratios of 24h- and zone-averaged mean enzyme levels. Experimental data taken from Dipietro and Weinhouse, 1960; Salas et al., 1963; Exton and
Park, 1965; Wimhurst and Manchester, 1970a; Chang and Schneider, 1971; Dunaway et al., 1978; Weinberg and Utter, 1980; Neely et al., 1981; Donofrio et al.,
1984; Miethke et al., 1985; Colosia et al., 1988; Crepin et al., 1988; Thorens et al., 1990; Miralpeix et al., 1992; Slieker et al., 1992; Gannon and Nuttall, 1997; Raju
et al., 1999; Manna and Jain, 2012.
4 days repeatedly with a 24 h glucose profile of a diabetic rat
until an almost stable 24 h pattern of protein abundances had
established (Figure 9). As shown in Figure 9D, all hepatocytes
work permanently as glucose producers, i.e., at all time points
of the day the intra-sinusoidal glucose concentration increases
along the portal-central axis (Figure 9A). The glycogen reserves
are drastically diminished and the different time courses of
glycogen emptying and filling between portal and central regions
(see Figure 2D) are completely abolished. Taken together, the
zonation of glucosemetabolism in the diabetic liver bears a strong
resemblance with that of the fasted liver. It is important to note
that even in this pathophysiological case the computed average
portal-to-central protein abundance ratios are in good agreement
with experimental data (see Figure 5).
DISCUSSION
Metabolic Zonation of Hepatic Glucose
Metabolism Is Driven by Concentration
Gradients of Hormones and Metabolites
In this work we used a mathematical model to study the
dynamic zonation of the hepatic glucose metabolism. To this
end we extended our previously published multi-scale tissue
model of the hepatic carbohydrate metabolism (Berndt et al.,
2018) by rendering the protein levels of key regulatory enzymes
of glycolysis and gluconeogenesis as dynamic model variables
which are controlled by timely variable synthesis and degradation
in dependence from the concentration of the four modulators
glucose, insulin, glucagon and oxygen. The model correctly
replicates experimentally determined protein levels in different
zones of the liver acinus as well as the adaptation of the liver to a
well-fed, fasted and diabetic state. From this we draw four main
conclusions. (1) Zonation of the hepatic glucose metabolism
is a necessary consequence of the fact that the expression of
key regulatory enzymes is controlled by modulators that display
a porto-central concentration gradient along the sinusoid. (2)
Mechanisms controlling the adaptation of enzyme abundances
to varying external conditions necessarily lead to the zonation
of hepatic carbohydrate metabolism. (3) The four modulators
considered in the model are sufficient to describe the dynamic
zonation of the glucose metabolism of the a normal liver. (4) The
use of phenomenological transfer functions which directly relate
the protein turnover to known modulators of gene expression
appears a promisingmodeling strategy to include variable protein
levels in kinetic models in view of the fact that in a foreseeable
future explicit kinetic modeling of complex gene-regulatory
network is out of reach.
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FIGURE 6 | Diurnal variations in the relative abundance of glycolytic and gluconeogenetic enzymes within hepatocytes along the porto-central axis during the
transition from a fed state (t = 0–24 h) to a fasted state (t > 24 h). The curves illustrate the relative deviation of protein abundances from the overall spatial and 24 h
mean (=24 h mean of the bold red curve). From the top to the bottom, the different curves refer to the spatial position of the hepatocyte counted from periportal to
percentral. The bold red line refers to the average protein abundance across all cells. The vertical dotted line indicates onset of the starvation period. (A) GlcT, (B)
G6PP, (C) GK, (D) PFK1, (E) FBPPFK1, (F) PFK2, (G) FBPPFK2, (H) PK, (I) PC, (J) PEPCK.
FIGURE 7 | Diurnal variations in the plasma levels of glucose (A), insulin (B), glucagon (C), cellular glycogen (D) and the glucose exchange flux (E) in different zones
along the porto-central axis during the transition from a well-fed state (t = 0–24 h) to a fasted state (t > 24 h) of the rate. The different curves refer to different spatial
positions of hepatocytes, counted from periportal (red curve) to percentral (green curve). The bold blue line refers to the means values of the shown variables. Note
that the red curves (= most portal cell) for the hormones and glucose are identical with their plasma profiles.
The Proposed Multi-Scale Model
Encompasses All Levels of Metabolic
Regulation
An important feature of the cellular metabolic network of the
liver is the ability to adapt its functional output to varying
external conditions such as changes in nutrient supply and
varying hormone levels. These adaptive mechanisms operate
at two different time scales. The short term adaptation
occurs within seconds or minutes and is brought about by
activity changes in the present metabolic enzymes by substrate
availability, allosteric regulation and reversible phosphorylation.
The second adaptive mechanism operates within hours or days
and is brought about by changes in the enzyme abundances. It
is already known for a long time that the total protein content
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of liver enzymes may largely vary owing to enhanced protein
degradation during fasting (providing glucogenic amino acids
as substrate for gluconeogenesis) mediated by the hormone
glucagon or enhanced protein synthesis by the hormone insulin
(Hopgood et al., 1980). However, such general changes of the
protein content do not tell anything about the changes in the
abundance of individual enzymes, whose expression by insulin
and glucagon differs profoundly. Therefore, it was necessary to
develop empirical rate laws for the synthesis and degradation
FIGURE 8 | Hepatic porto-venous glucose difference (AVGD) for the well-fed
and fasted nutritional state. The daily variations of plasma glucose in the
fasted, fed and well-fed state are indicated by the red-, green- and
blue-shaded areas. The solid lines represent the AVGD if in the fasted state
(red), fed state (green) and the well-fed state (blue). Crosses depict
experimentally measured AVGD (Huang and Veech, 1988).
of individual enzymes. This phenomenological approach was
chosen since currently biochemical information is insufficient
to establish molecular-resolved kinetic models which include,
for example, the interaction of transcription factors among each
other and with specific DNA promotor regions, the processing of
mRNA and the regulation of mRNA translation by micro RNAs
and RNA-binding proteins. For example, PEPCK, probably the
best-studied gluconeogenetic enzyme, is regulated by at least a
dozen transcription factors with partially unknown interactions
(Yang et al., 2009). Even if it was possible to explicitly model
the mRNA transcription for individual enzymes, there is still a
big gap in understanding post-transcriptional regulation and the
processes of post-translational modification.
Metabolic Response of the Liver to Varying
Nutritional Regimes
Our simulations suggest that in the presence of a constant daily
nutritional regime the diurnal variation of enzyme abundances
should be fairly moderate in the range of 10–20% around the
mean. This is a lot less than daily variations in the abundance
of the key regulatory enzyme of cholesterol synthesis, ßHMG-
CoA reductase (Kirkpatrick et al., 1980), exhibiting a pronounced
circadian rhythm or some enzymes of the amino acid metabolism
as, for example, tyrosine transaminase the activity of which is
almost four times as great several hours after nightfall as it is in
the morning (Wurtman, 1974). In contrast, much larger changes
of glycolytic and gluconeogenetic enzyme levels are elicited by a
switch from well-fed to fasting conditions and vice versa. This
metabolic adaptation occurs within a time span of several days
(see Figure 6) and enables vertebrates to maintain the plasma
glucose level in the absence of food. The slow change of enzyme
concentration profiles implies that the capability of the fasted
liver to clear a sudden excess of plasma glucose is diminished
(impaired glucose tolerance) as the capacity of glycolytic enzymes
and enzymes of the glycogen pathway a downregulated (Bulik
et al., 2016). Intriguingly, there appears to be a striking similarity
in the adaptive response of the liver to fasting conditions and
diabetes type 2. In our modeling approach, this is mainly due
to the fact that in both physiological settings the strong effect
of insulin on the expression of glycolytic and gluconeogenetic
FIGURE 9 | Diurnal variations in the plasma levels of glucose (A), insulin (B), glucagon (C), cellular glycogen (D), and the glucose exchange flux (E) in different zones
along the porto-central axis of a diabetic rat.
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enzymes is diminished whereas the effect of glucagon is
more pronounced. As demonstrated in a previous model-based
simulation study (König and Holzhütter, 2012), exposing the
permanently glucose-releasing “starved” liver of the diabetic
patient to a rigorous insulin treatment at persistently elevated
glucagon level may increase the risk of severe hypoglycaemia.
Thus, owing to the equally strong impact of both insulin and
glucagon on the expression and phosphorylation state of liver
enzymes, reconverting the “starved” liver of the diabetic patient
into the normal metabolic phenotype requires the normalization
of the plasma levels of both hormones.
Main Limitations of the Model and Outlook
for Future Model Extensions
The used multiscale tissue model comprises a number of
simplifications of the true anatomical structure of the liver which
may impact on the simulated intra-sinusoidal concentration
gradients of hormones and metabolites. For example, the blood
flow rate within the pericentral zone of the sinusoid may vary
if a sinusoid spreads out, forms anastomoses or merges with
another sinusoid (Rappaport et al., 1954), anatomic peculiarities
of liver parenchyma that are not yet considered in the STU
model. Also, the number of periportal hepatocytes is higher
(∼2–3-fold) compared to pericentral hepatocytes. Regarding the
concentration gradient of oxygen, hormones and metabolites in
the sinusoid it may be of relevance that the terminal branches of
the hepatic artery rarely join with the portal vein already before
the blood enters the sinusoids, as presumed in our model. In the
vast majority the merger of arterial blood with blood from the
portal vein, occurs a few cells downstream within the sinusoid
(Ekataksin and Kaneda, 1999) resulting in a local increase of the
concentration of oxygen concentration at this site. Despite these
limitations, the model correctly describes glucose exchange rates,
gradients and indicator dilution curves for a structurally normal
liver (Berndt et al., 2018). Hence, the functional implications
of the above limitations and other neglected aspects of the real
topology of liver tissue remain unclear. Therefore, in future
work we aim to embed our metabolic cell model in a 3-D
reconstructions of a mouse lobule (Hoehme et al., 2017).
The rate laws presented in this paper are effective transfer
functions describing directly the relation between modulators
(nutrients and hormones) and the turnover rate of a protein.
Usage of effective transfer function raises the question which
properties of the underlying regulatory network have to be
captured. Obviously, not all known modulators of protein
synthesis and degradation have been considered in the
model. Ground-breaking experiments pointed initially to the
oxygen gradient as the most important driving force of
metabolic zonation (Jungermann and Kietzmann, 1997, 2000).
Later experiments with isolated hepatocytes incubated with
varying concentrations of insulin or glucagon (Probst et al.,
1982) revealed an important role of these hormones for the
establishment of liver zonation. Meanwhile a lot more potential
modulators of metabolic zonation have been described in the
literature, among them Wnt/β-catenin pathway (Torre et al.,
2010; Vasilj et al., 2012), MAPK/ERK pathway (Zeller et al.,
2013), Hnf4-alpha (Colletti et al., 2009), or thyroid hormones
(Weinberg and Utter, 1979). However, as demonstrated in this
study, the dynamic zonation of the glucose metabolism can be
well described in different physiological settings by taken into
account only the four modulators oxygen, glucose, glucagon
and insulin. The central role of oxygen, glucose, glucagon and
insulin for the dynamic zonation of the glucose metabolism
does not exclude that morphogens and growth factors may
have an important role in the zonation of other metabolic
subsystems (Gebhardt and Matz-Soja, 2014). For example, the
expression of the glutamine synthetase is restricted to last few
hepatocytes close to the venous pole. Complementary, the urea
cycle enzyme carbamoylphosphate synthetase I (CPS I) is present
in the periportal, intermediate, and the first few layers of the
perivenous zone. It has been clearly demonstrated that Wnt/ß-
catenin signaling pathway plays a central role in the stable
maintenance of these peculiar zonation profiles (Burke et al.,
2009).
CONCLUSION
In summary, we propose a self-consistent model of liver
carbohydrate metabolism that consistently takes into account
variable gene expression of metabolic enzymes, regulation of
metabolic pathways, exchange of metabolites and hormones
between the blood and hepatocytes and microperfusion of the
liver. Once the input of hormones and nutrients to the periportal
region the liver acinus is known, the model allows to compute the
metabolic phenotype of individual hepatocytes along the porto-
central axis. The local hormone and metabolite concentrations
determine the phosphorylation state of the interconvertible
enzymes, hormonal clearance rates and expression level of
metabolic enzymes. The metabolic phenotype in turn determines
the functional output (here: glucose exchange rate) of each
hepatocyte and this way the venous glucose output of the acinus.
Integration across a representative set of acini yields finally the
total glucose output of the liver.
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